RS59033B1 - Polimeri koji vezuju protone za oralnu primenu - Google Patents

Polimeri koji vezuju protone za oralnu primenu

Info

Publication number
RS59033B1
RS59033B1 RS20190806A RSP20190806A RS59033B1 RS 59033 B1 RS59033 B1 RS 59033B1 RS 20190806 A RS20190806 A RS 20190806A RS P20190806 A RSP20190806 A RS P20190806A RS 59033 B1 RS59033 B1 RS 59033B1
Authority
RS
Serbia
Prior art keywords
amine
polymer
cross
pharmaceutical composition
bis
Prior art date
Application number
RS20190806A
Other languages
English (en)
Serbian (sr)
Inventor
Gerrit Klaerner
Eric F Connor
Randi K Gbur
Matthew J Kade
Paul H Kierstead
Jerry M Buysse
Michael J Cope
Kalpesh N Biyani
Son H Nguyen
Scott M Tabakman
Original Assignee
Tricida Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tricida Inc filed Critical Tricida Inc
Publication of RS59033B1 publication Critical patent/RS59033B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/024—Polyamines containing oxygen in the form of ether bonds in the main chain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4083—Concentrating samples by other techniques involving separation of suspended solids sedimentation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
RS20190806A 2013-06-05 2014-06-05 Polimeri koji vezuju protone za oralnu primenu RS59033B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361831445P 2013-06-05 2013-06-05
EP17177221.3A EP3287133B1 (en) 2013-06-05 2014-06-05 Proton-binding polymers for oral administration

Publications (1)

Publication Number Publication Date
RS59033B1 true RS59033B1 (sr) 2019-08-30

Family

ID=51212941

Family Applications (2)

Application Number Title Priority Date Filing Date
RS20190806A RS59033B1 (sr) 2013-06-05 2014-06-05 Polimeri koji vezuju protone za oralnu primenu
RS20201307A RS61005B1 (sr) 2013-06-05 2014-06-05 Polimeri koji vezuju protone za oralnu primenu

Family Applications After (1)

Application Number Title Priority Date Filing Date
RS20201307A RS61005B1 (sr) 2013-06-05 2014-06-05 Polimeri koji vezuju protone za oralnu primenu

Country Status (26)

Country Link
US (8) US9205107B2 (enExample)
EP (4) EP3287133B1 (enExample)
JP (5) JP6453860B2 (enExample)
KR (5) KR20240152425A (enExample)
CN (3) CN105377270B (enExample)
AU (3) AU2014274817B2 (enExample)
BR (1) BR112015030142B1 (enExample)
CA (1) CA2912911C (enExample)
CY (3) CY1119611T1 (enExample)
DK (3) DK3287133T3 (enExample)
ES (3) ES2834485T3 (enExample)
HK (1) HK1251151B (enExample)
HR (3) HRP20171590T1 (enExample)
HU (3) HUE051198T2 (enExample)
IL (3) IL242758B (enExample)
LT (3) LT3578185T (enExample)
MX (3) MX364785B (enExample)
NO (1) NO2905572T3 (enExample)
PL (2) PL3287133T3 (enExample)
PT (3) PT3287133T (enExample)
RS (2) RS59033B1 (enExample)
RU (1) RU2728778C2 (enExample)
SI (3) SI3287133T1 (enExample)
SM (2) SMT202000596T1 (enExample)
TR (1) TR201909355T4 (enExample)
WO (1) WO2014197725A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20171590T1 (hr) 2013-06-05 2017-12-29 Tricida Inc. Polimeri koji vežu protone za oralnu primjenu
PL3229816T3 (pl) * 2014-12-10 2020-09-21 Tricida Inc. Polimery wiążące protony do podawania doustnego
EP3452028A4 (en) * 2016-05-06 2020-04-15 Tricida Inc. COMPOSITIONS AND METHOD FOR TREATING ACID-BASED DISORDERS
KR20190084125A (ko) 2016-12-28 2019-07-15 후지필름 가부시키가이샤 질소 원자 함유 폴리머 또는 그 염의 유화액, 그 제조 방법, 및 입자의 제조 방법
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
WO2019078197A1 (ja) 2017-10-16 2019-04-25 富士フイルム株式会社 高リン血症治療剤
AU2018360868B2 (en) * 2017-11-03 2025-01-02 Tricida, Inc. Method of treating acid-base disorders
AU2018360867B2 (en) * 2017-11-03 2024-12-12 Tricida, Inc. Compositions for and method of treating acid-base disorders
CA3102765A1 (en) * 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
CN114450364A (zh) * 2019-07-19 2022-05-06 阿卡特肖勒公司 分子上定义明确的抗生物污损和聚离子涂层
FI4053179T3 (fi) 2021-03-01 2025-11-26 Renosis Inc Silloitettujen poly(allyyliamiini)polymeerien lääkekoostumuksia
CA3212512A1 (en) 2021-03-01 2022-09-09 Renosis, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
CN118510524A (zh) * 2021-12-14 2024-08-16 上海石趣医药科技有限公司 氧化银和/或其水合物在制备药物中的用途
CN115260355A (zh) * 2022-05-16 2022-11-01 江苏中天药业有限公司 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂
KR20240128205A (ko) 2023-02-17 2024-08-26 주식회사 쓰리디코리아 손잡이가 있는 운동기구용 개인별 맞춤형 그립 제조방법 및 그로써 제조된 개인별 맞춤형 그립
CN117164854A (zh) * 2023-07-07 2023-12-05 中国科学院长春应用化学研究所 一种交联型聚酰亚胺及其制备方法

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050090553A1 (en) 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
US6444221B1 (en) 1992-06-30 2002-09-03 Howard K. Shapiro Methods of treating chronic inflammatory diseases using carbonyl trapping agents
US5534259A (en) * 1993-07-08 1996-07-09 Liposome Technology, Inc. Polymer compound and coated particle composition
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5648355A (en) 1994-02-09 1997-07-15 Kos Pharmaceutical, Inc. Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
AU703842B2 (en) 1994-10-17 1999-04-01 Robert M. Bersin Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
US20020006899A1 (en) 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
US5753706A (en) 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
AUPO758297A0 (en) 1997-06-27 1997-07-24 Rowe, James Baber Control of acidic gut syndrome
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
EP2138191A1 (en) * 1998-01-05 2009-12-30 University Of Washington Enhanced transport using membrane disruptive agents
WO1999040990A1 (en) 1998-02-17 1999-08-19 University Of Maryland Anion binding polymers and the use thereof
US6485703B1 (en) 1998-07-31 2002-11-26 The Texas A&M University System Compositions and methods for analyte detection
US6271264B1 (en) 1998-12-01 2001-08-07 Geltex Pharmaceuticals, Inc. Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
US6844372B2 (en) 2000-03-09 2005-01-18 Hisamitsu Pharmaceutical Co., Inc. Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
WO2001066606A1 (en) 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Crosslinked anion-exchange resin or salt thereof
WO2001068106A1 (en) 2000-03-13 2001-09-20 Hisamitsu Pharmaceutical Co., Inc. Preventives and/or remedies for hyperphosphatemia
JP2002028737A (ja) 2000-07-07 2002-01-29 Fujitsu Ltd プレス打ち抜き加工方法及びプレス打ち抜き加工装置
BR0209020A (pt) * 2001-04-18 2004-08-10 Genzyme Corp Composição farmacêutica de polialilamina
EP1416942B1 (en) 2001-04-18 2007-12-12 Genzyme Corporation Amine polymers for treating gout and binding uric acid
EP1483232A1 (en) 2002-03-11 2004-12-08 Novartis AG Salts of nateglinide
AU2004210013A1 (en) 2003-02-10 2004-08-19 Autogen Research Pty Ltd Therapeutic molecules
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
CN1540136A (zh) * 2003-10-27 2004-10-27 华东理工大学 一种评价微生物驱油能力的方法
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
CA2551528A1 (en) 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
CA2553931A1 (en) 2004-01-29 2005-08-11 Keio University Erythrocyte function modifying substance
US7429394B2 (en) 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
PL1732523T3 (pl) 2004-03-30 2010-08-31 Vifor Pharma Tech Ltd Polimery wiążące potas i ich zastosowania
US7854924B2 (en) 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
US8282960B2 (en) 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US8192758B2 (en) 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US8399025B2 (en) 2004-06-04 2013-03-19 Board Of Regents, The University Of Texas System Polyamine modified particles
BRPI0513500C8 (pt) 2004-07-19 2022-06-14 Robert Johan Jozeph Hageman Uso de equivalentes de aspartato e composição nutricional ou farmacêutica
DE102004035808A1 (de) 2004-07-21 2006-03-16 Kasch, Helmut, Dr. Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20070293429A1 (en) 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
US20080214440A1 (en) 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
DE602005020501D1 (de) * 2004-10-13 2010-05-20 Ilypsa Inc Vernetzte aminpolymere
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
ITME20040015A1 (it) 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
WO2006078629A2 (en) * 2005-01-18 2006-07-27 Duke University In-situ crosslinkable elastin-like polypeptides for defect filling in cartilaginous tissue repair
AU2006264407B2 (en) 2005-07-04 2012-08-30 Ramu Krishnan Improved drug or pharmaceutical compounds and a preparation thereof
HUE025264T2 (en) 2005-08-18 2016-02-29 Panion & Bf Biotech Inc Pharmaceutical-grade ferric citrate for medical use
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP1928476A1 (en) * 2005-09-30 2008-06-11 Ilypsa, Inc. Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
WO2007038801A2 (en) 2005-09-30 2007-04-05 Ilypsa, Inc. Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
WO2007038802A2 (en) * 2005-09-30 2007-04-05 Ilypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
WO2007055044A1 (ja) 2005-11-08 2007-05-18 Ajinomoto Co., Inc. 麻酔覚醒促進剤
CA2626734A1 (en) 2005-11-08 2007-05-18 Genzyme Corporation Magnesium-containing polymers for the treatment of hyperphosphatemia
ITMI20052461A1 (it) 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
RU2008136081A (ru) 2006-02-14 2010-03-20 Тева Фармасьютикл Индастриес Лтд. (Il) Фармацевтические составы с алифатическими аминными полимерами и способы их производства
EP2016114A2 (en) 2006-05-05 2009-01-21 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
JP2009542653A (ja) 2006-07-05 2009-12-03 ジェンザイム コーポレーション リン酸塩過剰血症のための鉄（ｉｉ）含有治療剤
US20100124542A1 (en) 2006-07-18 2010-05-20 Genzyme Corporation Amine dendrimers
CN101541235A (zh) * 2006-07-18 2009-09-23 基酶有限公司 胺类树状物
US8391873B2 (en) 2006-07-21 2013-03-05 Qualcomm Incorporated Systems and methods for coordinating supplementary services for voice telephone calls in a centralized fashion
CA2660029A1 (en) 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
WO2008027551A2 (en) * 2006-09-01 2008-03-06 Genzyme Corporation Dendrimer compositions
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
JP2010502590A (ja) 2006-09-01 2010-01-28 ユーエスヴィー リミテッド セベラマー塩酸塩およびその処方物の調製のためのプロセス
EP2059247A1 (en) 2006-09-06 2009-05-20 Sucampo AG Method and composition for promoting gastrointestinal bicarbonate secretion
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
US20100129309A1 (en) 2007-02-23 2010-05-27 Dhal Pradeep K Amine polymer compositions
US20080207766A1 (en) 2007-02-27 2008-08-28 Agi Therapeutics Research Ltd. Methods and compositions for treating at least one upper gastrointestinal symptom
US20100196305A1 (en) 2007-03-08 2010-08-05 Dhal Pradeep K Sulfone polymer compositions
TWI445540B (zh) 2007-04-20 2014-07-21 Ajinomoto Kk 抗低體溫組成物
JP2010525061A (ja) 2007-04-27 2010-07-22 ゲンズイメ コーポレーション アミドアミンデンドリマー組成物
US8273384B2 (en) 2007-07-02 2012-09-25 Stephen Ray Wurzberger Process for the preparation of a non-corrosive base solution and methods of using same
EP2168992A1 (en) 2007-07-11 2010-03-31 Toray Industries, Inc. Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes
EP2016947A1 (en) 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
WO2009023544A2 (en) 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
US20090181359A1 (en) * 2007-10-25 2009-07-16 Lou Sheng C Method of performing ultra-sensitive immunoassays
US20090156647A1 (en) 2007-12-12 2009-06-18 Iovate T. & P. Inc. Method for maintaining physiological pH levels during intensive physical exercise
US20100316589A1 (en) 2007-12-14 2010-12-16 Hitesh Bhagat Coated Pharmaceutical Compositions
PA8807201A1 (es) 2007-12-14 2009-07-23 Genzyme Corp Composiciones farmaceuticas
WO2009097127A1 (en) 2008-01-31 2009-08-06 Genzyme Corporation Pharmaceutical compositions
EA201071059A1 (ru) 2008-03-11 2011-04-29 Лайвайонекс Инк. Способы и композиции для лечения воспаления и связанных с воспалением патологических состояний
WO2009125433A2 (en) 2008-04-08 2009-10-15 Usv Limited Process for preparation of amine polymer salt
EP2265238B1 (en) 2008-04-11 2012-01-11 GP Investimenti S.r.l. Handpiece for ultrasound treatments of human tissue
US20110142952A1 (en) 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
DE102008030046A1 (de) 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US20100008988A1 (en) 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
WO2010022381A1 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
US8337824B2 (en) 2008-08-22 2012-12-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
CN102223790B (zh) 2008-09-25 2015-11-25 维乌作物保护有限公司 生产聚合物纳米颗粒的方法和活性成分的制剂
US20110268666A1 (en) 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
US20100113479A1 (en) 2008-10-30 2010-05-06 Anusuya Choudhury Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
US20100166861A1 (en) 2008-12-29 2010-07-01 Kelly Noel Lynch Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
RU2011134847A (ru) 2009-01-22 2013-02-27 Юсв Лимитед Фармацевтические композиции, содержащие фосфатсвязывающий полимер
CA2777682C (en) 2009-10-13 2015-02-24 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
DK2490675T3 (en) 2009-10-22 2019-04-29 Synthon Bv Pharmaceutical compositions with sevelamer
WO2011071927A2 (en) 2009-12-07 2011-06-16 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
CA2790999C (en) * 2010-02-24 2019-05-14 Relypsa, Inc. Crosslinked polyvinylamine, polyallylamine, and polyethyleneimine for use as bile acid sequestrants
US9655920B2 (en) * 2010-02-24 2017-05-23 Relypsa, Inc. Amine polymers for use as bile acid sequestrants
JP5964247B2 (ja) * 2010-02-24 2016-08-03 レリプサ， インコーポレイテッド 胆汁酸捕捉剤として使用するためのポリイミダゾール
RU2417782C1 (ru) * 2010-03-03 2011-05-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия" Способ лечения ацидоза рубца
IT1406068B1 (it) 2010-07-22 2014-02-06 Medestea Int Spa Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego
JP2013535692A (ja) * 2010-08-10 2013-09-12 アムジエン・インコーポレーテツド 標的抗体に対する中和抗体検出用インビトロ二重機能標的結合アッセイ
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
KR101238210B1 (ko) 2011-06-30 2013-03-04 엘지전자 주식회사 이동 단말기
US20130137772A1 (en) 2011-11-29 2013-05-30 Raymond J. Bergeron Hydroxypolyamine salts
SG10201805177PA (en) 2012-06-21 2018-07-30 Keryx Biopharmaceuticals Inc Use of ferric citrate in the treatment of chronic kidney disease patients
CN119405686A (zh) 2012-10-08 2025-02-11 维福(国际)有限公司 治疗高血压和高血钾症的钾结合剂
HRP20171590T1 (hr) * 2013-06-05 2017-12-29 Tricida Inc. Polimeri koji vežu protone za oralnu primjenu
JP2016535780A (ja) 2013-11-04 2016-11-17 ケリク バイオファーマシューティカルス， インコーポレーテッド 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄
PL3229816T3 (pl) 2014-12-10 2020-09-21 Tricida Inc. Polimery wiążące protony do podawania doustnego
EP3452028A4 (en) 2016-05-06 2020-04-15 Tricida Inc. COMPOSITIONS AND METHOD FOR TREATING ACID-BASED DISORDERS
AU2018360867B2 (en) 2017-11-03 2024-12-12 Tricida, Inc. Compositions for and method of treating acid-base disorders
AU2018360868B2 (en) 2017-11-03 2025-01-02 Tricida, Inc. Method of treating acid-base disorders
WO2019236124A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
CA3102765A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
WO2019236639A1 (en) 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders

Also Published As

Publication number Publication date
NO2905572T3 (enExample) 2017-12-16
US20180015121A1 (en) 2018-01-18
SMT201900391T1 (it) 2019-09-09
KR20240023672A (ko) 2024-02-22
LT3003327T (lt) 2017-12-27
MX2019005300A (es) 2019-08-12
SMT202000596T1 (it) 2021-01-05
DK3578185T3 (da) 2020-11-02
EP3003327A1 (en) 2016-04-13
ES2733493T3 (es) 2019-11-29
JP6453860B2 (ja) 2019-01-16
US10369169B1 (en) 2019-08-06
JP6759316B2 (ja) 2020-09-23
JP2019065024A (ja) 2019-04-25
US20150056451A1 (en) 2015-02-26
CN111671767B (zh) 2024-03-08
PL3287133T3 (pl) 2019-10-31
BR112015030142A2 (pt) 2017-07-25
US20190231812A1 (en) 2019-08-01
IL242758B (en) 2020-01-30
JP2022107004A (ja) 2022-07-20
BR112015030142B1 (pt) 2023-03-07
US20180280428A1 (en) 2018-10-04
US20190134075A1 (en) 2019-05-09
CY1121801T1 (el) 2020-07-31
CA2912911C (en) 2023-10-03
JP7075455B2 (ja) 2022-05-25
LT3287133T (lt) 2019-07-10
US11197887B2 (en) 2021-12-14
MX2015016527A (es) 2016-07-22
EP3812761B1 (en) 2025-12-24
EP3287133A1 (en) 2018-02-28
AU2014274817B2 (en) 2019-05-23
EP3578185B1 (en) 2020-08-05
JP7588871B2 (ja) 2024-11-25
EP3578185A1 (en) 2019-12-11
CN111671766B (zh) 2024-03-08
SI3287133T1 (sl) 2019-09-30
US20200206260A1 (en) 2020-07-02
KR20230114326A (ko) 2023-08-01
AU2019219800B1 (en) 2019-09-19
AU2019275584A1 (en) 2020-01-02
IL278183B (en) 2021-09-30
EP3287133B1 (en) 2019-04-17
JP2016520652A (ja) 2016-07-14
HRP20191074T1 (hr) 2019-09-20
CN111671767A (zh) 2020-09-18
IL271932A (en) 2020-02-27
JP2020203917A (ja) 2020-12-24
ES2646271T3 (es) 2017-12-13
SI3003327T1 (en) 2018-01-31
HK1222120A1 (zh) 2017-06-23
MX387845B (es) 2025-03-19
HUE043999T2 (hu) 2019-09-30
MX2021013880A (es) 2022-06-02
US20220096534A1 (en) 2022-03-31
RU2015155596A (ru) 2017-07-18
CA2912911A1 (en) 2014-12-11
PT3578185T (pt) 2020-11-10
WO2014197725A1 (en) 2014-12-11
CY1123673T1 (el) 2022-03-24
KR102318910B1 (ko) 2021-10-29
HRP20171590T1 (hr) 2017-12-29
HRP20201767T1 (hr) 2020-12-25
US20160074430A1 (en) 2016-03-17
RU2728778C2 (ru) 2020-07-31
AU2014274817A1 (en) 2015-12-24
MX364785B (es) 2019-05-07
RU2015155596A3 (enExample) 2018-05-10
HUE034836T2 (en) 2018-03-28
KR20160041855A (ko) 2016-04-18
US9925214B2 (en) 2018-03-27
EP3003327B1 (en) 2017-08-09
DK3287133T3 (da) 2019-07-01
CY1119611T1 (el) 2018-04-04
KR102717667B1 (ko) 2024-10-16
PT3287133T (pt) 2019-07-12
KR102633597B1 (ko) 2024-02-06
SI3578185T1 (sl) 2021-01-29
US9205107B2 (en) 2015-12-08
HUE051198T2 (hu) 2021-03-01
ES2834485T3 (es) 2021-06-17
CN105377270A (zh) 2016-03-02
US10363268B2 (en) 2019-07-30
US9993500B2 (en) 2018-06-12
KR20240152425A (ko) 2024-10-21
AU2019275584B2 (en) 2021-10-21
IL271932B (en) 2020-11-30
PT3003327T (pt) 2017-11-09
PL3003327T3 (pl) 2018-02-28
KR20210131457A (ko) 2021-11-02
JP2025024009A (ja) 2025-02-19
US10391118B2 (en) 2019-08-27
CN105377270B (zh) 2020-09-04
CN111671766A (zh) 2020-09-18
TR201909355T4 (tr) 2019-07-22
HK1251151B (en) 2020-04-24
DK3003327T3 (en) 2017-10-23
RS61005B1 (sr) 2020-11-30
IL278183A (en) 2020-11-30
LT3578185T (lt) 2020-11-25
EP3812761A1 (en) 2021-04-28
HK1223288A1 (en) 2017-07-28

Similar Documents

Publication Publication Date Title
AU2019275584B2 (en) Proton-binding polymers for oral administration
JP7536343B2 (ja) 経口投与用プロトン結合ポリマー
HK1251151A1 (en) Proton-binding polymers for oral administration
HK40014989A (en) Proton-binding polymers for oral administration
HK40014989B (en) Proton-binding polymers for oral administration
HK1223288B (en) Proton-binding polymers for oral administration